Related Experiment Video
Updated: Feb 17, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
37.9K
Genetic Discrimination: A Case for a European Legislative Response?
European Journal of Health Law
|December 7, 2017
Summary
New genetic technologies present ethical challenges like genetic discrimination. The EU lacks unified regulation, with varying member state laws and international conventions influencing future policy. This paper examines EU genetic information regulation.
Area of Science:
- Bioethics
- Genetics Law
- European Union Policy
Background:
- Rapid advancements in genetic science and technology are ushering in a new era.
- Emerging ethical and legal issues, particularly genetic discrimination, pose risks to scientific progress without adequate regulation.
- The European Union (EU) currently lacks a unified legislative stance on genetic discrimination, resulting in fragmented approaches among Member States.
Purpose of the Study:
- To explore the current regulatory landscape of genetic information within the EU.
- To analyze the ethical and legal challenges posed by genetic discrimination in the context of scientific advancements.
- To consider international and transatlantic regulatory benchmarks in shaping EU policy.
Main Methods:
- Review of existing EU legislation and Member State approaches.
- Analysis of relevant international conventions, including the UN Convention on the Rights of Persons with Disabilities.
- Examination of the EU Charter of Fundamental Rights, Article 21.1.
- Comparative analysis with US federal legislation, such as the Genetic Information Non-Discrimination Act (GINA).
Main Results:
- The EU exhibits a patchwork of diverging legislative approaches to genetic discrimination.
- Key international and EU legal instruments, such as the EU Charter of Fundamental Rights, recognize the prohibition of discrimination based on genetic features.
- Transatlantic comparisons highlight existing legislative frameworks like the US GINA.
Conclusions:
- There is a recognized need for a more cohesive regulatory framework for genetic information in the EU.
- International and supranational legal frameworks provide a basis for addressing genetic discrimination.
- Future legislative action in the EU may be influenced by scientific developments and existing international and transatlantic regulatory models.
Related Concept Videos
What is Genetic Engineering?
80.5K
Overview
80.5K
Stereotypes, Prejudice, and Discrimination
95.5K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
95.5K
Genetic Screens
5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Incomplete Dominance
30.2K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.2K
Pharmacogenomics: Identification of New Drug Targets
10
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
10
Principles of Pharmacogenetics: Types of Genetic Variants
14
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
14

